USFDA nod to Zydus for production of Fluphenazine Hydrochloride
Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets). This medication is used to treat symptoms of a certain type of mental/mood condition (schizophrenia). Fluphenazine belongs to a class of medications called phenothiazines and is also referred to as a neuroleptic.
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad. The group now has 318 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Recent Posts
India Reports Highest Tuberculosis Cases in 2024 Amid Progress in TB Control
India has recorded its highest-ever number of tuberculosis (TB) cases in 2024, with 26.07 lakh…
Elon Musk’s 120-Hour Workweek: The Dark Reality
Elon Musk is known for his relentless work ethic and high expectations from his teams.…
Patanjali’s Renogrit: A Breakthrough in Kidney Protection During Cancer Treatment
In 2024, a significant advancement in nephroprotection emerged from Patanjali Research Institute with the development…
Sunita Williams & Butch Wilmore’s 45-Day Rehab After Space Mission
NASA astronauts Sunita Williams and Barry "Butch" Wilmore have returned to Earth after an extended…
Bacterial Meningitis: The Silent Threat You Can’t Ignore
Bacterial meningitis is a life-threatening infection that leads to inflammation of the meninges, the protective…
Rare Human Coronavirus HKU1 Detected in Kolkata
A 45-year-old woman from Kolkata has been diagnosed with human coronavirus HKU1 (HCoV-HKU1), a rare…